TCMBANKIN014143 |
rel-(2s,5r,6r,8s,9s,10r,18s,19r)-diacetoxy-18,19-epoxy-6-hydroxy-2-(2-methylbutanoyloxy)cleroda-3,13(16),14-triene |
|
C29H42O8 |
|
|
TCMBANKIN041038 |
caseamembrin d |
|
C33H48O10 |
604.7 g/mol |
CCCC(=O)OC1C2=CC(CC3C2(C(C(C(C3(C)CCC(=C)C=C)C)OC(=O)C)O)C(O1)OC(=O)C)OC(=O)C(C)CC |
TCMBANKIN042092 |
casearlucin a |
|
C29H42O8 |
518.6 g/mol |
CCC(C)C(=O)OC1CC2C(C(CC(C23C(OC(C3=C1)OC(=O)C)OC(=O)C)O)C)(C)CC=C(C)C=C |
TCMBANKIN042101 |
stigmast-5-ene-3β,7β-diol |
|
C29H50O2 |
|
|
TCMBANKIN043804 |
Caseamemin |
|
|
|
|
TCMBANKIN044253 |
Casealactone |
casealactone |
|
0 |
|
TCMBANKIN044342 |
casearimene b |
|
C20H32O |
|
CC1=CCCC(=CCC2(CCC(=C)C(C2(C)C)CC1)O)C |
TCMBANKIN044750 |
caseamembrin f |
|
C25H36O5 |
416.5 g/mol |
CCC(C)C(=O)OC1CC2C(C(CC(C2(C(=C1)C=O)C=O)O)C)(C)CCC(=C)C=C |
TCMBANKIN045472 |
caseamembrin a |
|
C31H46O8 |
546.7 g/mol |
CCCC(=O)OC1C2=CC(CC3C2(C(CC(C3(C)CCC(=C)C=C)C)O)C(O1)OC(=O)C)OC(=O)C(C)CC |
TCMBANKIN046747 |
caseamembrin b |
|
C28H42O7 |
490.6 g/mol |
CCC(C)C(=O)OC1CC2C(C(CC(C23C(OC(C3=C1)OC)OC(=O)C)O)C)(C)CCC(=C)C=C |
TCMBANKIN048242 |
caseamembrin c |
|
C31H46O9 |
562.7 g/mol |
CCCC(=O)OC1C2=CC(CC3C2(C(C(C(C3(C)CCC(=C)C=C)C)O)O)C(O1)OC(=O)C)OC(=O)C(C)CC |
TCMBANKIN048751 |
casearinone |
|
C17H20O7 |
|
COC1=CC(=CC(=C1O)OC)C2(C(=CC(=O)C=C2OC)OC)OC |
TCMBANKIN048794 |
casearimene a |
|
C20H30O2 |
|
|
TCMBANKIN049262 |
Caseamembrin E |
|
|
|
|
TCMBANKIN049674 |
caseamembrol b |
|
C29H42O9 |
|
CCC(C)C(=O)OC1CC2C(C(CC(C23C(OC(C3=C1)OC(=O)C)OC(=O)C)O)C)(C)CC(C(=C)C=C)O |
TCMBANKIN049718 |
Caseamembrol A |
|
|
518.6 g/mol |
|
TCMBANKIN058388 |
Morkit |
NCGC00094960-01; Anthracene, 9,10-dihydro-9,10-dioxo-; Anthraquinone [BSI:ISO]; PS926_SUPELCO; Spectrum4_000907; 9,10-Anthracendion; SPBio_000330; ZINC03847491; Hoelite; KBio2_007143; AIDS-001365; SpecPlus_000645; anthra-9,10-quinone; BSPBio_003141; 9,10-Anthracenedione; C16207; 45327_RIEDEL; KBio1_001685; SPECTRUM1502103; Corbit; DivK1c_006741; KBio2_002007; Caswell No. 052A; 9,10-Dioxoanthracene; A90004_ALDRICH; Spectrum5_001897; KBio2_004575; 790240-52-7; ANTHRAQUINONE; InChI=1/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8; CHEBI:40448; KBio3_002641; Anthrapel; 84-65-1; NCGC00094960-02; Spectrum2_000405; KBioSS_002007; 9,10-Anthrachinon; EINECS 201-549-0; Bis-alkylamino anthraquinone; NCGC00094960-03; CCRIS 649; NSC 7957; Anthrachinon; AI3-09073; NSC7957; ST5410412; Anthradione; HSDB 2074; KBioGR_001374; Spectrum_001527; EPA Pesticide Chemical Code 122701; 9,10-Anthrachinon [Czech]; 9,10-Anthraquinone; AIDS001365; Spectrum3_001501; anthracene-9,10-dione; AN-24075; Melting point standard 283-286 inverted exclamation markaC; MolPort-001-783-170; D0L5LN; BBL003001; Anthracene-9,10-quinone; KBio2_007143; MCULE-4655011423; KBio2_002007; LS-1837; Morkit; T8216; K513; ST24024605; 9,10-quinone; HMS1921J14; Anthraquinone 100 microg/mL in Acetonitrile; Bis-alkylamino anthraquinone; 9,10-Anthraguinone; Az-Q; Anthracene,10-dihydro-9,10-dioxo-; TRA0074021; Epitope ID:116191; Anthraquinone, purum, >=99.0% (HPLC); STK398385; anthracene-9,10-dione; SBB060613; Melting point standard 283-286C, analytical standard; AK117080; DSSTox_CID_95; Spectrum4_000907; Tox21_111369; UNII-030MS0JBDO; 9,10-Anthracendion; CAS-84-65-1; SpecPlus_000645; NCGC00094960-06; 9,10-Anthracenedione; 9,10-dihydro-9,10-dioxoanthracene; AC1Q6JY1; DSSTox_GSID_20095; Morkie; 9,10-dihydroanthracene-9,10-dione; KBio3_002641; 84-65-1; AB-131/40003277; KBioSS_002007; A0502; EINECS 201-549-0; CCRIS 649; SC-46775; Anthrachinon; BDBM50094892; HSDB 2074; KBioGR_001374; EPA Pesticide Chemical Code 122701; 9,10-Anthrachinon [Czech]; Tox21_111369_1; KBio2_004575; 9,10-anthrachinoe; Spectrum3_001501; NCGC00094960-01; SR-01000944707-1; ZINC3847491; TR-031315; Anthracene, 9,10-dihydro-9,10-dioxo-; Anthraquinone, 97%; KSC362C5J; Anthracenequinone; BSPBio_003141; Anthraquinone, analytical standard; Anthraquinone, Vetec(TM) reagent grade, 97%; AC-12719; SPECTRUM1502103; MFCD00001188; Caswell No. 052A; 030MS0JBDO; Spectrum5_001897; CHEBI:40448; InChI=1/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8; F0001-2133; Spectrum2_000405; NCGC00094960-02; RP26414; NCGC00094960-03; KB-74706; NSC 7957; DTXSID3020095; DS-4810; 9,10-Anthraquinone; I14-1219; RTR-031315; ST50410412; DB-005409; Anthraquinone [BSI:ISO]; FT-0622417; Anthra-9,10-quinone #; SPBio_000330; EC 201-549-0; Hoelite; NCGC00094960-04; Anthraquinone, PESTANAL(R), analytical standard; C16207; SCHEMBL14943; KBio1_001685; Corbit; AJ-45864; CHEMBL55659; DivK1c_006741; Anthra-9,10-quinone; DSSTox_RID_75364; BG01517201; 9,10-Dioxoanthracene; NSC-7957; ANTHRAQUINONE; Anthrapel; ACMC-209pw0; AC1L1NAG; SR-01000944707; 9,10-Anthrachinon; RZVHIXYEVGDQDX-UHFFFAOYSA-N; AI3-09073; NSC7957; Anthradione; Spectrum_001527; CCG-39966; AKOS000282964; ANW-37822; anthraquinone |
C14H8O2 |
208.21 |
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O |
TCMBANKIN058837 |
Supraene |
trans-Squalene; SQUALENE; 94016-35-0; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-; (E,E,E,E)-Squalene; InChI=1/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24; 442785_SUPELCO; Squalene, Spinacene, Supraene; AIDS-017396; 2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; All-trans-Squalene; 111-02-4; EINECS 203-826-1; (14E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-,; S3626_SIGMA; 7683-64-9; CHEBI:15440; 2,6,10,14,18,22-tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)-; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; AIDS017396; Spinacene; C00751; NSC93748; (all-E)-2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene; LMPR01060008; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (all-E)-; CCRIS 711; (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene;squalene |
C30H50 |
410.72 |
CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C |
TCMBANKIN060140 |
friedelan-3-one |
|
C30H50O |
426.7 g/mol |
CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C |
TCMBANKIN060687 |
Hydroxysitosterol |
|
C29H50O2 |
430.71 |
CCC(CCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)C(C)C |
TCMBANKIN060689 |
stigmastane-3β,5α,6β-triol |
|
C29H52O3 |
|
CCC(CCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)O)C)C(C)C |
TCMBANKIN061561 |
vanillic acid |
CJ-02984; CHEBI:16632; Vanillate; CHEBI:30816; H36001_ALDRICH; InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11; BRN 2208364; WKOLLVMJNQIZCI-UHFFFAOYSA-M; 94770_FLUKA; WLN: QVR DQ CO1; MLS000574833; Acide vanillique; vanillicacid; C06672; m-Anisic acid, 4-hydroxy-; VA (VAN); vanil-lic acid; 4-Hydroxy-3-methoxybenzoic acidion; 4-Hydroxy-3-methoxybenzoic acid; Protocatechuic acid, 3-methyl ester; NSC3987; NSC 674322; DB02130; VANILLIC ACID; p-Vanillic acid; NSC 3987; ZB010900; 4-Hydroxy-3-methoxybenzoate; AIDS-018089; p-Hydroxy-m-methoxy-benzonic acid; 3-Methoxy-4-hydroxybenzoic acid; 4-hydroxy-3-methoxy-benzoic acid; NSC674322; 6746-48-1; 121-34-6; AC1L2LVA; Benzoic acid, 4-hydroxy-3-methoxy-; AI3-19542; SMR000156289; AIDS018089; SBB008280; W398802_ALDRICH; EINECS 204-466-8; 4-hydroxy-3-methoxy benzoic acid; 3-methoxy-4-hydroxybenzoic acid |
C8H8O4 |
168.15 g/mol |
COC1=C(C=CC(=C1)C(=O)O)O |
TCMBANKIN061574 |
feruloyltyramine |
n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine |
C18H19NO4 |
313.3 g/mol |
COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
TCMBANKIN061752 |
Syringaldehyde |
BP-12551; W-108274; SYRINGIC ALDEHYDE; TL8000818; F2190-0619; 3,5-Dimethoxy-4-hydroxybenzene carbonal; SBB007558; syringaldehyde; Benzaldehyde,5-dimethoxy-4-hydroxy-; 134S963; Syringaldehyde (3,5-Dimethoxy-4-hydroxybenzaldehyde); MolPort-000-871-246; 4-08-00-02718 (Beilstein Handbook Reference); AC-7993; Syringylaldehyde; RP24321; Benzaldehyde, 4-hydroxy-3,5-dimethoxy-; 3,5-Dimethoxy-4-Hydroxy-Benzaldehyde; M-5269; BBL023037; CJ-01202; BB_NC-1418; 3,5-Dimethoxy-4-hydroxybenzaldehyde; 134-96-3; DTXSID2059643; AK-58336; Gallaldehyde 3,5-dimethyl ethel; Syringaldehyde, 98%; EINECS 205-167-5; NSC 41153; AIDS-340410; MCULE-3798898100; CD0099; AB1002509; 86220_FLUKA; FT-0618631; AI3-28796; D0635; Syringealdehyde; S7602_ALDRICH; Syringaldehyde, analytical standard; 4-Hydroxy-3,5-dimethoxybenzaldehydl; AN-8414; CHEBI:67380; AJ-12845; InChI=1/C9H10O4/c1-12-7-3-6(5-10)4-8(13-2)9(7)11/h3-5,11H,1-2H; Syringaldehyde, Vetec(TM) reagent grade, 98%; KCDXJAYRVLXPFO-UHFFFAOYSA-N; BG00602125; 3,5-DIMETHOXY-4-HYDROXYBENZALDEHYDE, PURE; STR09162; UNII-2ZR01KTT21; Syringaldehyde, >=98%, FG; 3,5-Dimethoxy-4-hydroxybenzaldehyde; 4-Hydroxy-3,5-dimethoxybenzaldehyde; TR-004732; ST093694; NSC-41153; RTR-004732; AT-3143; Syringe aldehyde; 4CN-0961; 4-hydroxy-3,5-dimethoxy-benzaldehyde; CTK0H4628; 4-Hydroksy-3,5-dwumetoksybenzaldehyd [Polish]; 3,5-Dimethoxy-4-hydroxy benzaldehyde; ANW-19730; bmse010204; syringaldehye; KSC174M2R; 4-hydroxy-3,5-dimethoxy benzaldehyde; bmse000595; KB-60663; AP-065/41884112; Cedar aldehyde; MFCD00006943; Springaldehyde; ACMC-209bxg; ZINC152926; BRN 0784514; AIDS340410; SC-50428; AKOS000119539; CHEMBL225303; 4-Hydroxy-3,5-dimethoxybenzaldehyde; SYRINGALDEHYDE; NSC41153; SCHEMBL150376; 4-Hydroksy-3,5-dwumetoksybenzaldehyd; CS-0016810; I01-1214; Benzaldehyde, 3,5-dimethoxy-4-hydroxy-; Gallaldehyde 3,5-dimethyl ether; AC1Q489M; AC1L1RFP; STK801968; LS-25017; Syringic aldehyde; 2ZR01KTT21; ZINC00152926; J10333; W404926_ALDRICH; ST2411453;syringic aldehyde;3,5-dimethoxy-4-hydroxybenzaldehyde;yringaldehyde |
C9H10O4 |
182.17 g/mol |
COC1=CC(=CC(=C1O)OC)C=O |